What's New

“What’s New” is a content series that shines a spotlight on employees across the Group who are putting into practice The Alfresa Group's Philosophy and the three themes set out in the Alfresa Group's Medium- to Long-Term Vision—“Extending healthy life expectancy,” “Contributing to community healthcare,” and “Healthcare innovation”—and shares their aspirations and actions through storytelling.

2026.09.29

Delivering Needed Pharmaceuticals Reliably, Safely and Sincerely to Medical Institutions
- Challenges Taken on by a Delivery Specialist (DS) Section Chief Who Supports Delivery Quality and Ease of Working -

2026.07.16

Taking on Challenges for the Future of Regenerative Medicine - Through Cooperation Between Cell Resources Corporation and Korean CDMO ENCell Co., Ltd. -

2026.03.19

“Mydodes”: Meeting the Medical Frontline’s Need for Answers - Fast- Streamlining Medical Information to Solve On-site Challenges and Build Trust -

2025.12.02

Partnership for a Disaster-Resilient Society
Conclusion of Agreement Between Alfresa Healthcare Corporation and Haleon Japan K.K. Regarding Cooperation During Disasters

2025.09.30

Alfresa Holdings Corporation Opens Up Japan's Biosimilar Market
- A New Challenge in a Government-led Projec

2025.07.30

Future Envisioned by Docshiru
GEKKA WORKS' Efforts to Create a World in
Which Everyone Can Receive the Optimum
Healthcare

2025.07.16

Meisho Co., Ltd. Signs Health Promotion
Agreement with Toyama City
A New Challenge Inspired by the Corporate Philosophy:
"Contributing to the Health and Happiness of Local Residents"

2025.05.07

Toward the Launch of Haneda PDC:
Cell Resources Corporation's Strategic Move
Bringing the hope of regenerative medicine to all

2025.04.03

Team Spirit on Display at the 2025 Life Support Fair
Pointing toward a new destination in wellness

2025.03.06

Uncovering New Value in High-Quality Drugs to Cure Rare Diseases and Underserved Medical Conditions
Capital and Business Alliance with GEXVal Inc.

2025.03.04

Using Drones for the Stable Delivery of Pharmaceuticals
TS Alfresa Corporation concludes an agreement with Japan Drone Organization and Hatsukaichi City, Hiroshima Prefecture, to cooperate in disaster relief activities using unmanned aircrafts

2025.02.05

Aspiring to Accelerate CO₂ Emission Reductions Across the Alfresa Group
Deploying 45 EVs Across Five Locations of Alfresa Corporation and A·L Plus Co., Ltd.

  • View more